The Food and Drug Administration (FDA) has approved the first gene therapy for the treatment of Duchenne muscular dystrophy (DMD) in children from age 4 through 5 years of age. Pediatric patients who ...
Your muscles need continuous maintenance to stay strong and healthy. Duchenne muscular dystrophy (DMD) happens when there is a change in a person's genetic instructions that affects the production of ...
CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, today announced the launch of "A Cure Can't Wait," a national public service announcement (PSA ...
The first gene therapy for children with Duchenne muscular dystrophy has been approved by the U.S. Food and Drug Administration. The therapy can be used in 4- and 5-year-olds with the degenerative ...
Muscle tissue damage appears when muscular dystrophy is induced in a mouse model (middle). But when researchers block the function of two genes that drive unwanted mitochondrial pore formation (right) ...
Gene therapies have extended survival in muscular dystrophy, requiring improved care transitions from pediatric to adult systems. Current systems lack adequate staffing, specialists, and communication ...
The Christian Post on MSNOpinion
'Why not you?': Mom draws on faith while caring for son with terminal disease
When Angelina Olivera cried out to God and asked why she had been called to help a family member walk the path of Duchenne ...
A family in England is speaking up after their daughter lost years of her life to treatment for an illness she didn’t have.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results